Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dithranol 0.1% cream
1305020F0AACZCZ
|
Dithranol (Topical) | Dithranol | Skin | 105 |
|
Dithranol 1% cream
1305020F0AABMBM
|
Dithranol (Topical) | Dithranol | Skin | 72 |
|
Dithrocream 0.1% cream
1305020F0BIACCZ
|
Dithrocream | Dithranol | Skin | 70 |
|
Dithranol 0.25% cream
1305020F0AABKBK
|
Dithranol (Topical) | Dithranol | Skin | 66 |
|
Dithranol 0.5% cream
1305020F0AADADA
|
Dithranol (Topical) | Dithranol | Skin | 53 |
|
Dithrocream 0.5% cream
1305020F0BIADDA
|
Dithrocream | Dithranol | Skin | 43 |
|
Dithrocream 0.25% cream
1305020F0BIAABK
|
Dithrocream | Dithranol | Skin | 41 |
|
Dithrocream 1% cream
1305020F0BIABBM
|
Dithrocream | Dithranol | Skin | 22 |
|
Dithranol 2% cream
1305020F0AADBDB
|
Dithranol (Topical) | Dithranol | Skin | 15 |
|
Dithranol 0.4% ointment
1305020F0AACWCW
|
Dithranol (Topical) | Dithranol | Skin | 9 |
|
Dithrocream 2% cream
1305020F0BIAEDB
|
Dithrocream | Dithranol | Skin | 3 |
|
Dithranol 1% in Zinc and Salicylic acid paste
1305020F0AAEQEQ
|
Dithranol (Topical) | Dithranol | Skin | 2 |
|
Dithranol 0.1% in Zinc and Salicylic acid paste
1305020F0AAETET
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dithranol 0.5% in Zinc and Salicylic acid paste
1305020F0AAFAFA
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dith 0.4%/Salic acid 2%/EW 25% in liq paraffin to 100% oint
1305020F0AAEZEZ
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 0.01% in Yellow soft paraffin
1305020F0AAEUEU
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 0.1% in Yellow soft paraffin
1305020F0AAEYEY
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 0.25% / Salicylic acid 1.6% scalp gel
1309000V0AAAAAA
|
Dithranol (Scalp) | Dithranol | Skin | No data available |
|
Dithranol 0.4% in White soft paraffin
1305020F0AAEWEW
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 10% / Salicylic acid 2% in Emulsifying ointment
1305020F0AAEKEK
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 10% in Emulsifying ointment
1305020F0AAESES
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 2% in White soft paraffin
1305020F0AAEJEJ
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 2% in Yellow soft paraffin
1305020F0AAEVEV
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 3% cream
1305020F0AADTDT
|
Dithranol (Topical) | Dithranol | Skin | No data available |
|
Dithranol 3% ointment
1305020F0AACVCV
|
Dithranol (Topical) | Dithranol | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.